Meitav Investment House’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Hold |
43,210
| – | – | 0.02% | 142 |
|
|
2025
Q1 | $1.23M | Buy |
43,210
+350
| +0.8% | +$9.92K | 0.02% | 124 |
|
|
2024
Q4 | $1.78M | Sell |
42,860
-184,043
| -81% | -$7.65M | 0.03% | 114 |
|
|
2024
Q3 | $15.2M | Buy |
226,903
+111,475
| +97% | +$7.45M | 0.25% | 71 |
|
|
2024
Q2 | $13.7M | Sell |
115,428
-51,978
| -31% | -$6.17M | 0.24% | 70 |
|
|
2024
Q1 | $17.8M | Buy |
167,406
+96
| +0.1% | +$10.2K | 0.35% | 66 |
|
|
2023
Q4 | $16.6M | Buy |
167,310
+16
| +0% | +$1.59K | 0.24% | 87 |
|
|
2023
Q3 | $16.9M | Buy |
167,294
+12,189
| +8% | +$1.23M | 0.27% | 84 |
|
|
2023
Q2 | $18.9M | Hold |
155,105
| – | – | 0.3% | 83 |
|
|
2023
Q1 | $20.8M | Buy |
155,105
+132,259
| +579% | +$17.7M | 0.36% | 77 |
|
|
2022
Q4 | $4.1M | Hold |
22,846
| – | – | 0.07% | 151 |
|
|
2022
Q3 | $2.7M | Buy |
22,846
+65
| +0.3% | +$7.68K | 0.05% | 177 |
|
|
2022
Q2 | $3.25M | Buy |
22,781
+7,839
| +52% | +$1.12M | 0.06% | 166 |
|
|
2022
Q1 | $2.57M | Buy |
+14,942
| New | +$2.57M | 0.04% | 200 |
|